BHVN
Biohaven Pharmaceutical Holding Company Ltd

3,274
Mkt Cap
$1B
Volume
5.03M
52W High
$47.75
52W Low
$7.48
PE Ratio
-1.25
BHVN Fundamentals
Price
$9.63
Prev Close
$9.46
Open
$9.67
50D MA
$14.04
Beta
1.71
Avg. Volume
2.14M
EPS (Annual)
-$9.28
P/B
-58.33
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Morgan Stanley Issues Pessimistic Forecast for Biohaven (NYSE:BHVN) Stock Price
Morgan Stanley reduced their price target on shares of Biohaven from $54.00 to $26.00 and set an "overweight" rating on the stock in a report on Tuesday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Insider Buying: Biohaven (NYSE:BHVN) CAO Buys 17,000 Shares of Stock
Biohaven Ltd. (NYSE:BHVN - Get Free Report) CAO George Clark bought 17,000 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The shares were acquired at an average...
MarketBeat·1d ago
News Placeholder
ARS Investment Partners LLC Purchases 148,255 Shares of Biohaven Ltd. $BHVN
ARS Investment Partners LLC grew its position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 14.3% during the second quarter, according to its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Biohaven (NYSE:BHVN) Shares Gap Up After Insider Buying Activity
Biohaven (NYSE:BHVN) Shares Gap Up Following Insider Buying Activity...
MarketBeat·2d ago
News Placeholder
Gregory Bailey Purchases 400,000 Shares of Biohaven (NYSE:BHVN) Stock
Biohaven Ltd. (NYSE:BHVN - Get Free Report) Director Gregory Bailey acquired 400,000 shares of the firm's stock in a transaction that occurred on Thursday, November 13th. The shares were bought at an...
MarketBeat·2d ago
News Placeholder
Candriam S.C.A. Acquires 34,664 Shares of Biohaven Ltd. $BHVN
Candriam S.C.A. raised its holdings in Biohaven Ltd. (NYSE:BHVN - Free Report) by 36.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission...
MarketBeat·4d ago
News Placeholder
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eighteen ratings firms that are presently covering the stock...
MarketBeat·4d ago
News Placeholder
Citigroup Lowers Biohaven (NYSE:BHVN) Price Target to $14.00
Citigroup cut their price target on shares of Biohaven from $28.00 to $14.00 and set a "buy" rating on the stock in a research report on Thursday...
MarketBeat·6d ago
News Placeholder
Biohaven (NYSE:BHVN) Trading 5% Higher - Here's What Happened
Biohaven (NYSE:BHVN) Stock Price Up 5% - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M Biohaven Announces...
PR Newswire·7d ago

Latest BHVN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.